Evaluation of Curetis Unyvero, a multiplex PCR-based testing system, for rapid detection of bacteria and antibiotic resistance and impact of the assay on management of severe nosocomial pneumonia
- PMID: 24789196
- PMCID: PMC4097734
- DOI: 10.1128/JCM.00325-14
Evaluation of Curetis Unyvero, a multiplex PCR-based testing system, for rapid detection of bacteria and antibiotic resistance and impact of the assay on management of severe nosocomial pneumonia
Abstract
Health care-associated pneumonia due to multidrug-resistant organisms represents a major therapeutic challenge. Unfortunately, treatment is dependent on empirical therapy, which often leads to improper and inadequate antimicrobial therapy. A rapid multiplex PCR-based Unyvero pneumonia application (UPA) assay that assists in timely decision-making has recently become available. In this study, we evaluated the performance of UPA in detecting etiological pathogens and resistance markers in patients with nosocomial pneumonia (NP). The impact of this assay on the management of severe nosocomial pneumonia was also assessed. Appropriate specimens were processed by UPA according to the manufacturer's protocol in parallel with conventional culture methods. Of the 56 patients recruited into the study, 49 (87.5%) were evaluable. Of these, 27 (55.1%) and 4 (8.2%) harbored multiple bacteria by the PCR assay and conventional culture, respectively. A single pathogen was detected in 8 (16.3%) and 4 (8.2%) patients, respectively. Thirteen different genes were detected from 38 patients, including the ermB gene (40.8%), the blaOXA-51-like gene (28.6%), the sul1 (28.6%) and int1 (20.4%) integrase genes, and the mecA and blaCTX-M genes (12.3% each). The time from sample testing to results was 4 h versus 48 to 96 h by UPA and culture, respectively. Initial empirical treatment was changed within 5 to 6 h in 33 (67.3%) patients based on the availability of UPA results. Thirty (62.2%) of the patients improved clinically. A total of 3 (6.1%) patients died, mainly from their comorbidities. These data demonstrate the potential of a multiplex PCR-based assay for accurate and timely detection of etiological agents of NP, multidrug-resistant (MDR) organisms, and resistance markers, which can guide clinicians in making early antibiotic adjustments.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.
Similar articles
-
Assessment of the multiplex PCR-based assay Unyvero pneumonia application for detection of bacterial pathogens and antibiotic resistance genes in children and neonates.Infection. 2018 Apr;46(2):189-196. doi: 10.1007/s15010-017-1088-y. Epub 2017 Oct 31. Infection. 2018. PMID: 29086343
-
Evaluation of the multiplex PCR based assay Unyvero implant and tissue infection application for pathogen and antibiotic resistance gene detection in children and neonates.Infection. 2019 Apr;47(2):195-200. doi: 10.1007/s15010-018-1192-7. Epub 2018 Aug 21. Infection. 2019. PMID: 30132251
-
An evaluation of the Unyvero pneumonia system for rapid detection of microorganisms and resistance markers of lower respiratory infections-a multicenter prospective study on ICU patients.Eur J Clin Microbiol Infect Dis. 2021 Oct;40(10):2113-2121. doi: 10.1007/s10096-021-04259-6. Epub 2021 May 1. Eur J Clin Microbiol Infect Dis. 2021. PMID: 33934275
-
Antibiotic resistance in nosocomial respiratory infections.Clin Lab Med. 2014 Jun;34(2):257-70. doi: 10.1016/j.cll.2014.02.004. Epub 2014 Apr 13. Clin Lab Med. 2014. PMID: 24856527 Review.
-
Nosocomial pneumonia. Diagnostic and therapeutic considerations.Med Clin North Am. 2001 Jan;85(1):79-114. doi: 10.1016/s0025-7125(05)70305-9. Med Clin North Am. 2001. PMID: 11190353 Review.
Cited by
-
Evaluation of multiplex polymerase chain reaction as an alternative to conventional antibiotic sensitivity test.Vet World. 2018 Apr;11(4):474-479. doi: 10.14202/vetworld.2018.474-479. Epub 2018 Apr 13. Vet World. 2018. PMID: 29805213 Free PMC article.
-
The Unyvero P55 'sample-in, answer-out' pneumonia assay: A performance evaluation.Biomol Detect Quantif. 2017 Jun 28;13:1-6. doi: 10.1016/j.bdq.2017.06.001. eCollection 2017 Sep. Biomol Detect Quantif. 2017. PMID: 29021968 Free PMC article.
-
Bioluminogenic Probe for Rapid, Ultrasensitive Detection of β-Lactam-Resistant Bacteria.Anal Chem. 2023 May 9;95(18):7329-7335. doi: 10.1021/acs.analchem.3c00478. Epub 2023 Apr 21. Anal Chem. 2023. PMID: 37083185 Free PMC article.
-
Evaluation of a Novel Multiplex PCR Panel Compared to Quantitative Bacterial Culture for Diagnosis of Lower Respiratory Tract Infections.J Clin Microbiol. 2020 Apr 23;58(5):e02013-19. doi: 10.1128/JCM.02013-19. Print 2020 Apr 23. J Clin Microbiol. 2020. PMID: 32075901 Free PMC article.
-
Optimizing Antimicrobial Drug Dosing in Critically Ill Patients.Microorganisms. 2021 Jun 28;9(7):1401. doi: 10.3390/microorganisms9071401. Microorganisms. 2021. PMID: 34203510 Free PMC article. Review.
References
-
- Vincent J-L, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin MH, Wolff M, Spencer RC, Hemmer M. 1995. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 274:639–644 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous